Skip to main content
. 2022 Oct 20;82(14):1453–1468. doi: 10.1007/s40265-022-01785-1

Table 3.

Potential scenarios of the positive effect of ICSs in bronchiectasis

High peripheral eosinophilic counts in bronchiectasis
Asthma
Severe COPD
ABPA
Increasing uncontrolled mucus secretion
Eosinophilic bronchial inflammation

ABPA allergic bronchopulmonary aspergillosis, COPD chronic obstructive pulmonary disease, ICSs inhaled corticosteroids